Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 16 ... concluded: "The observed reduction in SIP level might be associated with the standard antiplatelet treatment given to patients since thrombocytes are one of the major sources of plasma ...
2009 NOV 23 ... (platelet count 1,000,000/mu L or greater) in trauma patients and to examine the role of antiplatelet agents in its treatment. The Los Angeles County Medical Center trauma registry was used ...
2009 NOV 29 ... of research seeking to evaluate and understand possible sex differences associated with antiplatelet therapies. This study-the first to look at the impact of clopidogrel, one of the most ...
2009 NOV 16 ... data in the information system, consisting of glycemic control, lipid control, and antiplatelet therapy. For process indicators, the percentages of patients with a yearly measured ...
2009 NOV 16 ... (IVH) is a serious complication of intracerebral hemorrhage (ICH). We hypothesized that antiplatelet medication use and platelet activity would be associated with more IVH," scientists ...
2009 NOV 9 ... colleagues. The researchers concluded: "The principal themes are choice of antiplatelet therapy, statin therapy, blood pressure control, choice of intra-operative heparin, the ...
2009 NOV 16 ... Germany, "Clopidogrel hydrogensulfate is a thienopyridine acting as an important antiplatelet agent alone or in combination with acetyl salicylic acid to prevent cardiovascular ...
2009 NOV 9 ... mean CHADS2 score was 2. The baseline use of either oral anticoagulant therapy or antiplatelet agent alone was 60%. Dronedarone reduced the risk of stroke from 1.8% per year to 1.2% ...
2009 NOV 23 ... during craniotomy. Clinical feature In one patient with coronary bare metal stent and antiplatelet therapy, acetylsalicylic acid and clopidogrel was discontinued 5 and 11 days prior to ...
2009 NOV 23 ... lesions were identified, we performed a skin biopsy, platelet count measurements, and antiplatelet-factor 4 antibody and allergy testing. We enrolled 320 patients. In total, 24 patients ...
2009 NOV 23 ... these compounds are devoid of bleeding side effects often observed with other types of antiplatelet drugs, which constitutes a promising advantage for this new class of antithrombotic ...
2009 NOV 23 ... studies attests to higher bleeding rates among elderly individuals with AF. Antiplatelet therapy is not effective for stroke prevention in AF and is also associated with ...
